Interferon Alpha Signalling and Its Relevance for the Upregulatory Effect of Transporter Proteins Associated with Antigen Processing (TAP) in Patients with Malignant Melanoma

Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial

(2015) Alexander M M Eggermont et al.   LANCET ONCOLOGY

Characterization of SLCO5A1/OATP5A1, a Solute Carrier Transport Protein with Non-Classical Function

(2013) Katrin Sebastian et al.   PLoS One

Epidermal Expression of Neuropilin 1 Protects Murine keratinocytes from UVB-induced apoptosis

(2012) Anna Riese et al.   PLoS One

Conformation of peptides bound to the transporter associated with antigen processing (TAP)

(2011) M. Herget et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Interferon alpha regulates MAPK and STAT1 pathways in human hepatoma cells

(2011) Lan-Juan Zhao et al.   Virology Journal

A polymorphism associated with STAT3 expression and response of chronic myeloid leukemia to interferon  

(2010) S. Kreil et al.   HAEMATOLOGICA

Interferon Alpha Adjuvant Therapy in Patients With High-Risk Melanoma: A Systematic Review and Meta-analysis

(2010) S. Mocellin et al.   JNCI-Journal of the National Cancer Institute

Advanced Malignant Melanoma: Immunologic and Multimodal Therapeutic Strategies

(2010) Niels Halama et al.   Journal of Oncology

Interferon-alpha treatment may negatively influence disease progression in melanoma patients by hyperactivation of STAT3 protein

(2009) L. Humpoliková-Adámková et al.   EUROPEAN JOURNAL OF CANCER

Structural arrangement of the transmission interface in the antigen ABC transport complex TAP

(2009) G. Oancea et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Impact of IFNα2b upon pSTAT3 and the MEK/ERK MAPK Pathway in Melanoma

(2008) Wenjun Wang et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Differential expression of influx and efflux transport proteins in human antigen presenting cells

(2008) Claudia Skazik et al.   EXPERIMENTAL DERMATOLOGY

Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial

(2008) Alexander MM Eggermont et al.   LANCET